3Uckun F M, Vallera D A, Wee S L. B lymphocte regulation of human hematopoiesis[ J]. J Immunol, 1985; 135(6) : 3817-3822.
4Bohm W, Schirmbeck R,Elbe A et al. Exogenous hepatitis B surface antigen particles progressed by dendritic cells or macrophages prime murine MHC class I-reacted cytotoxic T lymphocytes in vivo[J].J Immunol,1995; 155(7) : 3313-3321.
5Torsteinsdottir S, Masucci M G,Brautbar C et al. Differential recognition of tumor-derived and in vitro Epstein-Barr virus-transformed B-cell lines by fetal calf serum-specific T4-positive cytotoxic T-lymphocyte clones[J].Cell Immunol, 1986;98(2) :453-466.
二级参考文献3
1[1]Inaba K. lnaba M, Romani N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor[J]. J Exp Med, 1992; 176:1693-1702.
2[2]Sallusto F ,Lanzavecchia A.Efficient presentation of soluble antigen by cultured human dendritic cells is maintianed by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α [J].J Exp Med, 1994;179:1109-1117.
3[3]Chapuis F,Rosenzwajg M, Yagello M, et al. Differentiation of human dendritic cells from monocytes in vitro[J]. Eur J Immunol. 1997;27:431-441.
1Almand B,Resser JR,Lindman B,et al.Clinical significance of defective dendritic cell differentiation in cancer.Clin Cancer Res,2000,6(5):1 755-1 766.
2Khanna R,Moss DJ,Burrows SR.Vaccine strategies against epstein-barr virus-associated diseases:lessons from studies on cytotoxic T-Cell-mediated immune regulation.Immunol Rev,1999,170:49-64.
3Lin CL,Lo WF,Lee TH,et al.Immunization with epstein-Barr Virus (EBV) peptide-pulsed dendritic cells Induces functional CD8^+ T-Cell immunity and may lead to tumor regression in patients with EBV-Positive na-sopharyngeal carcinoma.Cancer Res,2002,62(23):6 952-6 958.
